Newsroom | 5785 results

Sorted by: Latest

Alternative Medicine
-

Definium Therapeutics to Participate at Upcoming Investor Conferences and Events

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (Nasdaq: DFTX) ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company’s management team will participate in the following investor conferences and events: Stifel Hosted Webinar: Definium Therapeutics Virtual Fireside Chat Presentation Date and Time: T...
-

Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma

ATHLONE, Ireland--(BUSINESS WIRE)--Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma...
-

Go dēhp® and dēhp® Theraputic Sponsor the 2026 Southwestern School for Behavioral Health Studies Conference and Present Proprietary Dehp® High Treatment to Attendees

PHOENIX--(BUSINESS WIRE)--Go dēhp® and dēhp® Theraputic invite health care professionals attending the 58th Annual Southwestern School for Behavioral Health Studies Conference to attend a special session on their proprietary Dehp® High Treatment. Taking place at Gila River Resorts & Casinos – Wild Horse Pass in Chandler, Arizona, the conference is sponsored by Go dēhp® and dēhp® Theraputic, The Dehp® High Treatment session will be presented by Go dēhp® and dēhp® Theraputic CEO Josette Sulli...
-

Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the Company has mailed (or mailed a notice of internet availability with respect to) its proxy statement and fiscal 2026 annual report to shareholders (collectively, the “Meeting Materials”) for its Annual General and Special Meeting of shareholders (the “Meeting”) sche...
-

Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that its Kincardine, Ontario cultivation facility (“Kincardine”) has received renewed European Union Good Manufacturing Practice (“EU GMP”) certification from the Regierungspräsidium Tübingen – Leitstelle Arzneimittelüberwachung Baden-Württemberg. With its EU GMP status...
-

LeAnn Rimes Joins Inaugural Next Health Longevity Summit in Nashville as Featured Panelist

NASHVILLE, Tenn.--(BUSINESS WIRE)--Grammy winner LeAnn Rimes joins the inaugural Next Health Longevity Summit in Nashville (Sept. 12) as a featured panelist....
-

RejuvenX Names Emilie Ray Chief Executive Officer

SARASOTA, Fla.--(BUSINESS WIRE)--RejuvenX announces the appointment of Emilie Ray as President and Chief Executive Officer....
-

WM Technology, Inc. Reports Second Quarter 2026 Financial Results

IRVINE, Calif.--(BUSINESS WIRE)--WM Technology, Inc. (“WM Technology” or the “Company”) (OTC: MAPS), a leading marketplace and technology solutions provider to the cannabis industry, today announced its financial results for the second quarter ended June 30, 2026. “The cannabis industry is entering a more demanding phase, particularly in established markets where sustained economic and regulatory pressures continue to reshape the competitive landscape,” said Doug Francis, CEO and Chairman of WM...
-

Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026, and will participate in a fireside chat at 8:00am ET. Management will also participate in the Stifel Biotech Summit in Newport, Rhode Island, on August 10, 2026. A live audio webcast of this event wil...
-

Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA

CHICAGO--(BUSINESS WIRE)--Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA...